As of May 22
| -0.08 / -1.37%|
The 4 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 7.50, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +30.66% increase from the last price of 5.74.
The current consensus among 5 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.